drugset / Trial / NCT07439250
A Study of Olomorasib (LY3537982) in Healthy Participants
NaSingle-groupOpen-labelBasic science
Summary
The main purpose of this study in healthy participants is to determine the effect of fluconazole on the amount of study drug that gets into the bloodstream and how long it takes the body to get rid of it. For each participant, the study will last up to approximately 7 weeks and will require 12 overnight stays in the research center.
Timeline
- Start
- 2026-03-02
- Primary completion
- 2026-04-17
- Completion
- 2026-04-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluconazole | Small molecule | — | Oral |
| Subject | Olomorasib | Small molecule | — | Oral |
Indications
No indication recorded.